http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Biolase (BIOL) Enters Partnership for TeamSmile Program
-
BIOLASE ANNOUNCES SUPPORT FOR TEAMSMILE PROGRAM
-
BIOLASE ANNOUNCES SUPPORT FOR PROJECT HOME
-
BIOLASE ANNOUNCES ADVANCING DENTISTRY WEBINARS FOR Q3 2022
-
BIOLASE ANNOUNCES ADVANCING DENTISTRY PODCAST
-
BIOLASE ANNOUNCES INAUGURAL CLINICAL EXCELLENCE FORUM
-
BIOLASE SIGNS LEASE TO EXPAND TRAINING AND EDUCATION INITIATIVES
-
BIOLASE TO PRESENT AT LD MICRO INVITATIONAL INVESTOR CONFERENCE ON JUNE 8, 2022
-
BIOLASE CREATES FIRST-OF-ITS-KIND CLINICAL INTEGRATION TEAM
-
BIOLASE CEO SHARES VISION FOR KINDLER, GENTLER DENTISTRY WITH CUSTOMERS AROUND THE WORLD
-
BIOLASE TO PARTICIPATE IN THE SPRING INTO ACTION BEST IDEAS VIRTUAL INVESTOR CONFERENCE MAY 17-20, 2022
-
Biolase (BIOL) Regains Nasdaq Compliance
-
BIOLASE REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
-
BIOLASE MAINTAINS GROWTH MOMENTUM AS FIRST QUARTER REVENUE INCREASED 25% YEAR OVER YEAR
-
Biolase (BIOL) Appoints Kenneth P. Yale to its Board
-
BIOLASE STRENGTHENS ITS BOARD OF DIRECTORS WITH ADDITION OF SEASONED HEALTHCARE EXECUTIVE
-
BIOLASE, Inc to Report First Quarter 2022 Results on May 12, 2022
-
Biolase (BIOL) Announces 1-for-25 Reverse Stock Split
-
BIOLASE ANNOUNCES 1-FOR-25 REVERSE STOCK SPLIT
-
BIOLASE TO PARTICIPATE IN MAXIM GROUP'S 2022 VIRTUAL GROWTH CONFERENCE HOSTED BY M-VEST ON MARCH 28TH - 30TH
-
BIOLASE REPORTS CONTINUED GROWTH FOR FOURTH QUARTER AND FULL YEAR 2021
-
BIOLASE to Report Fourth Quarter and Full Year 2021 Results on March 17, 2022
-
BIOLASE Announces Distribution of Series G Preferred Stock to Holders of Its Common Stock
-
BIOLASE Announces Continuation of Exclusive Collaboration with BMW Performance Center West (BMW PCW) and Winner of BMW Sweepstakes
-
Biolase (BIOL) Extends Exclusive Collaboration with BMW Performance Center West
-
BIOLASE Announces Continuation of Exclusive Collaboration with BMW Performance Center West (BMW PCW) and Winner of BMW Sweepstakes
-
Biolase (BIOL) Announces Preliminary 2021 Fourth Quarter Results
-
BIOLASE ANNOUNCES POSTIVE PRELIMINARY REVENUE RESULTS FOR 2021 FOURTH QUARTER; ENTERS 2022 WITH SIGNIFICANT MOMENTUM
-
Biolase (BIOL) and EdgeEndo Granted FDA 510(k) Clearance of New EdgePRO Laser-Assisted Microfluidic Irrigation Device for Endodontists
-
BIOLASE and EdgeEndo Announce FDA 510(k) Clearance of New EdgePRO Laser-Assisted Microfluidic Irrigation Device for Endodontists
-
BIOLASE TO PRESENT AT THE H.C. WAINWRIGHT BIOCONNECT VIRTUAL INVESTOR CONFERENCE
-
Biolase (BIOL) Announces Nasdaq Grants it 180-Day Extension To Meet Minimum Bid Price Requirement And Enters Into Favorable Credit Agreement Amendment
-
Nasdaq Grants BIOLASE 180-Day Extension To Meet Minimum Bid Price Requirement And Enters Into Favorable Credit Agreement Amendment
-
BIOLASE To Present At The Benchmark Company Discovery One-On-One Virtual Investor Conference On December 2, 2021
-
BIOLASE Urges Stockholders to Vote Now "FOR" Reverse Stock Split
-
BIOLASE Reports 46% Revenue Growth In 2021 Third Quarter; Demand For Dental Lasers From New Customers Remains High And Continues To Fuel Growth
-
Leading Independent Proxy Advisory Firms Glass Lewis and ISS Recommend BIOLASE Stockholders Vote "FOR" Reverse Stock Split
-
BIOLASE Announces the Launch of Epic Hygiene Academy
-
BIOLASE, Inc to Report Third Quarter 2021 Results on November 10, 2021
-
BIOLASE Issues Letter To Stockholders
-
BIOLASE To Host Q&A And Webcast For Investors Regarding Its Special Meeting Of Stockholders
-
BIOLASE and Healthy Smiles for Kids of Orange County (Healthy Smiles) Invite California Dental Community to Awareness Reception on Sept. 24
-
BIOLASE Schedule Of Investor Conferences For September 2021
-
BIOLASE Announces Clinical Advisory Partnership with Leading Endodontist Dr. L. Stephen Buchanan
-
Biolase (BIOL) Appoints Kathleen T. O'Loughlin, Carol Gomez Summerhays, and Martha Somerman to its Board
-
BIOLASE Expands Core Capabilities As It Appoints Three New Board Members With Significant Dental Experience
-
BIOLASE Reports Significantly Improved Revenue In Its Second Quarter As Continued High Demand For Dental Lasers From New Customers Fueled Growth
-
BIOLASE, Inc. To Report Second Quarter 2021 Results On August 12, 2021
-
Biolase (BIOL) Announces Recent Studies Demonstrate Waterlase Laser Technology is Beneficial for Treatment of Peri-Implantitis
-
Recent Studies Demonstrate BIOLASE's Waterlase Laser Technology is Beneficial for Treatment of Peri-Implantitis

